Thermo Fisher Scientific Acquires Finnzymes

Thermo Fisher Scientific has signed a definitive agreement to acquire Finnzymes, a Finland-based provider of PCR enzymes, reagents, instruments and consumables. The acquisition expands Thermo Fisher's molecular biology and diagnostics portfolio by adding Finnzymes' proprietary DNA polymerases, miniaturized thermal cyclers and consumables; Finnzymes is headquartered in Espoo, Finland and had about 90 employees and $20 million revenue in 2009.